America’s biopharmaceutical companies have joined forces to fight COVID-19. Armed with experience garnered from previous outbreaks and a vast storehouse of knowledge about infectious diseases like influenza, malaria and HIV, researchers are working to develop and deliver diagnostics, treatments and vaccines to save lives and restore the rhythms of daily life for billions of people.
Below is a new graphic illustrating how America’s biopharmaceutical companies are utilizing diagnostics, existing medicines, new treatments, manufacturing, and vaccines for one shared goal: Fighting COVID-19.
You can also get the latest on the biopharmaceutical industry’s efforts to beat COVID-19 here.
Tom Wilbur
Tom Wilbur is Deputy Vice President of Public Affairs at PhRMA where he leads the state public affairs team and Voters for Cures, PhRMA’s grassroots advocacy initiative. Prior to joining PhRMA in 2019, Tom served as a senior aide on Capitol Hill for U.S. Rep. Fred Upton and the House Energy and Commerce Committee. Tom holds an M.A. in strategic communications from Michigan State University and a B.A. in social science and history from Central Michigan University. He enjoys spending time with family and friends, volunteering, reading and golfing.
New poll: Americans agree that expanding the TRIPS waiver will harm U.S. global manufacturing and innovation leadership
WHO Pandemic Agreement offers opportunities and risks for American innovators
What you should know about protecting your health this fall
What you need to know: COVID-19 public health emergency is over, but ideological attacks on IP remain
New infographic: How we are fighting COVID-19
Coronavirus
New infographic: How we are fighting COVID-19
New infographic: How we are fighting COVID-19